FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030174875> ?p ?o ?g. }

• W2030174875 endingPage "114" @default.
• W2030174875 startingPage "106" @default.
• W2030174875 abstract "To determine whether exclusive radiotherapy could be a therapeutic option after complete clinical response (cCR) to neoadjuvant chemotherapy (NCT) for early breast cancers (EBC).Between 1985 and 1999, 1477 patients received néoadjuvante chemotherapy for early breast cancer considered to be too large for primary conservative surgery. Of 165 patients with complete clinical response, 65 were treated by breast surgery (with radiotherapy) and 100 by exclusive radiotherapy.The two groups were comparable in terms of baseline characteristics, except for larger initial tumor sizes in the exclusive radiotherapy group. There were no significant differences in overall, disease-free and metastasis-free survivals. Five-year and 10-year overall survivals were 91 and 77% in the no surgery group and 82 and 79% in the surgery group, respectively (P = 0.9). However, a non-significant trend towards higher locoregional recurrence rates (LRR) was observed in the no surgery group (31 vs. 17% at 10 years; P = 0.06). In patients with complete responses on mammography and/or ultrasound, LRR were not significantly different (P=0.45, 10-year LRR: 21 in surgery vs. 26% in exclusive radiotherapy). No significant differences were observed in terms of the rate of cutaneous, cardiac or pulmonary toxicities.Surgery is a key component of locoregional treatment for breast cancers that achieved complete clinical response to neoadjuvant chemotherapy." @default.
• W2030174875 created "2016-06-24" @default.
• W2030174875 creator A5003301011 @default.
• W2030174875 creator A5005535965 @default.
• W2030174875 creator A5010843537 @default.
• W2030174875 creator A5012593402 @default.
• W2030174875 creator A5015202957 @default.
• W2030174875 creator A5026747686 @default.
• W2030174875 creator A5032350168 @default.
• W2030174875 creator A5046764240 @default.
• W2030174875 creator A5055495127 @default.
• W2030174875 creator A5062609687 @default.
• W2030174875 creator A5073631057 @default.
• W2030174875 date "2011-04-01" @default.
• W2030174875 modified "2023-09-26" @default.
• W2030174875 title "Cancers du sein de stade II-IIIA : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?" @default.
• W2030174875 cites W1497080962 @default.
• W2030174875 cites W1576023464 @default.
• W2030174875 cites W1754020298 @default.
• W2030174875 cites W1967594797 @default.
• W2030174875 cites W1971268210 @default.
• W2030174875 cites W1972156333 @default.
• W2030174875 cites W1973896410 @default.
• W2030174875 cites W1994155838 @default.
• W2030174875 cites W2004371499 @default.
• W2030174875 cites W2019294563 @default.
• W2030174875 cites W2026981776 @default.
• W2030174875 cites W2028938009 @default.
• W2030174875 cites W2052025976 @default.
• W2030174875 cites W2052977461 @default.
• W2030174875 cites W2082655656 @default.
• W2030174875 cites W2093274522 @default.
• W2030174875 cites W2099944170 @default.
• W2030174875 cites W2111953585 @default.
• W2030174875 cites W2113244094 @default.
• W2030174875 cites W2132025287 @default.
• W2030174875 cites W2134269295 @default.
• W2030174875 cites W2153158488 @default.
• W2030174875 cites W2153369531 @default.
• W2030174875 cites W2162760540 @default.
• W2030174875 cites W2166283970 @default.
• W2030174875 cites W2167952584 @default.
• W2030174875 cites W2171958606 @default.
• W2030174875 cites W2287271371 @default.
• W2030174875 cites W79845059 @default.
• W2030174875 doi "https://doi.org/10.1016/j.canrad.2010.06.020" @default.
• W2030174875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21084207" @default.
• W2030174875 hasPublicationYear "2011" @default.
• W2030174875 type Work @default.
• W2030174875 sameAs 2030174875 @default.
• W2030174875 citedByCount "3" @default.
• W2030174875 countsByYear W20301748752015 @default.
• W2030174875 countsByYear W20301748752018 @default.
• W2030174875 crossrefType "journal-article" @default.
• W2030174875 hasAuthorship W2030174875A5003301011 @default.
• W2030174875 hasAuthorship W2030174875A5005535965 @default.
• W2030174875 hasAuthorship W2030174875A5010843537 @default.
• W2030174875 hasAuthorship W2030174875A5012593402 @default.
• W2030174875 hasAuthorship W2030174875A5015202957 @default.
• W2030174875 hasAuthorship W2030174875A5026747686 @default.
• W2030174875 hasAuthorship W2030174875A5032350168 @default.
• W2030174875 hasAuthorship W2030174875A5046764240 @default.
• W2030174875 hasAuthorship W2030174875A5055495127 @default.
• W2030174875 hasAuthorship W2030174875A5062609687 @default.
• W2030174875 hasAuthorship W2030174875A5073631057 @default.
• W2030174875 hasConcept C121608353 @default.
• W2030174875 hasConcept C126322002 @default.
• W2030174875 hasConcept C141071460 @default.
• W2030174875 hasConcept C143998085 @default.
• W2030174875 hasConcept C2776694085 @default.
• W2030174875 hasConcept C2777757722 @default.
• W2030174875 hasConcept C2779013556 @default.
• W2030174875 hasConcept C2781467025 @default.
• W2030174875 hasConcept C3019926457 @default.
• W2030174875 hasConcept C509974204 @default.
• W2030174875 hasConcept C530470458 @default.
• W2030174875 hasConcept C71924100 @default.
• W2030174875 hasConceptScore W2030174875C121608353 @default.
• W2030174875 hasConceptScore W2030174875C126322002 @default.
• W2030174875 hasConceptScore W2030174875C141071460 @default.
• W2030174875 hasConceptScore W2030174875C143998085 @default.
• W2030174875 hasConceptScore W2030174875C2776694085 @default.
• W2030174875 hasConceptScore W2030174875C2777757722 @default.
• W2030174875 hasConceptScore W2030174875C2779013556 @default.
• W2030174875 hasConceptScore W2030174875C2781467025 @default.
• W2030174875 hasConceptScore W2030174875C3019926457 @default.
• W2030174875 hasConceptScore W2030174875C509974204 @default.
• W2030174875 hasConceptScore W2030174875C530470458 @default.
• W2030174875 hasConceptScore W2030174875C71924100 @default.
• W2030174875 hasIssue "2" @default.
• W2030174875 hasLocation W20301748751 @default.
• W2030174875 hasLocation W20301748752 @default.
• W2030174875 hasOpenAccess W2030174875 @default.
• W2030174875 hasPrimaryLocation W20301748751 @default.
• W2030174875 hasRelatedWork W1936813410 @default.
• W2030174875 hasRelatedWork W1970677298 @default.
• W2030174875 hasRelatedWork W2106734666 @default.
• W2030174875 hasRelatedWork W2161568138 @default.

• next